¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"amyloid degeneration"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fibrinoid degeneration
    ¼¶À¯¼Ò¸ð¾çº¯¼º, ÇǺ기¸ð¾çº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º
  • hydropic degeneration
    ¼öÆ÷º¯¼º
  • lattice degeneration
    °ÝÀÚº¯¼º
  • liquefaction degeneration
    ¾×È­º¯¼º
  • malignant degeneration
    ¾Ç¼ºº¯¼º
  • myopic degeneration
    ±Ù½Ãº¯¼º
  • microcystic degeneration
    ¹Ì¼¼³¶º¯¼º
  • nodular colloid degeneration
    °áÀýÄÝ·ÎÀ̵庯¼º
  • postencephalitic degeneration
    ³ú¿°Èĺ¯¼º
  • parenchymatous degeneration
    ½ÇÁúº¯¼º
  • pallidal degeneration
    â¹éÇÙº¯¼º
  • red degeneration
    Àû»öº¯¼º
  • reticular degeneration
    ±×¹°º¯¼º, ¸Á»óº¯¼º
  • retrograde degeneration
    ¿ªÇຯ¼º, ¿ª¹æÇ⺯¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • endoglobular degeneration
    Ç÷±¸³»º¯¼º
  • equatorial degeneration
    Àûµµº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º
  • hydropic degeneration
    ¼öÆ÷º¯¼º
  • lattice degeneration
    °ÝÀÚº¯¼º
  • liquefaction degeneration
    ¾×È­º¯¼º
  • malignant degeneration
    ¾Ç¼ºº¯¼º
  • microcystic degeneration
    ¹Ì¼¼³¶º¯¼º
  • myopic degeneration
    ±Ù½Ãº¯¼º
  • nodular colloid degeneration
    °áÀý±³Áúº¯¼º
  • pallidal degeneration
    â¹éÇÙº¯¼º
  • parenchymatous degeneration
    ½ÇÁúº¯¼º
  • red degeneration
    Àû»öº¯¼º
  • reticular degeneration
    ±×¹°º¯¼º
  • retrograde degeneration
    ¿ªÇຯ¼º, ¿ª¹æÇ⺯¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯ ¼º.
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯ ¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º.
  • hereditary macular degeneration
    À¯Àü¼º Ȳ¹Ýº¯¼º(ë¶îîàõüÜÚèܨàõ).
  • hyaloideoretinal degeneration
    À¯¸®Ã¼¸Á¸·º¯¼º
  • pigmentary degeneration of retina
    ¸Á¸·»ö¼Òº¯¼º(Áõ)(ØÑدßäáÈܨàõ(ñø))
  • pigmentary retinal degeneration
    ¸Á¸·»ö¼Òº¯¼º
  • pigmentary retinal degeneration
    ¸Á¸·»ö¼Òº¯¼º(Áõ).(ØÑدßäáÈܨàõ(ñø))
  • posterolateral degeneration of spinal cord
    ô¼öÈÄÃø¼º º¯¼º(ô±âÐý­ö°àõܨ àõ).
  • posterolateral degeneration of spinal cord
    ô¼öÈÄÃø¼º º¯¼º(ô±âÐý­ö°àõ ܨàõ)
  • primary degeneration
    ÀÏÂ÷º¯¼º(ìéó­Ü¨àõ)
  • progressive lenticular degeneration
    ÁøÇ༺ ·»ÁîÇÙº¯¼º(Áõ)(òäú¼àõ¡­ú·Ü¨àõ(ñø))
  • pyramidal degeneration
    Ãßüº¯¼º(õÞô÷ܨàõ)
  • red degeneration
    Àû»öº¯¼º(îåßäܨàõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • alcoholic cerebellar degeneration
    ¾ËÄڿüº ¼Ò³úº¯¼º(¡­á³Òàܨàõ).
  • angiolithic degeneration
    ¸Æ°ü°á¼®¼º º¯¼º(ØæÎ·Ì¿à´àõܨàõ).
  • ballooning degeneration
    dz¼±º¯¼º
  • basophilic degeneration
    È£¿°±â¼º º¯¼º(¡­Ü¨àõ)
  • calcareous corneal degeneration
    ¼®È¸°¢¸·º¯¼º
  • cell,hydropic degeneration
    ¼öÆ÷¼º º¯¼º(â©øÜàõܨà÷)
  • cerebellar degeneration
    ¼Ò³úº¯¼º
  • cerebellar degeneration
    ¼Ò³úº¯¼º(¡­Ü¨àõ)
  • cerebromacular degeneration
    ³úȲ¹Ýº¯¼º(Áõ).
  • cobblestone degeneration
    ÀÚ°¥¸ð¾çº¯¼º, Æ÷¼®»óº¯¼º
  • corneal degeneration
    °¢¸·º¯¼º
  • cystic degeneration
    ³¶º¯¼º
  • degeneration
    º¯¼º, ÅðÈ­
  • degeneration, cellular
    º¯¼º, ¼¼Æ÷¼º(á¬øààõ)
  • disciform macular degeneration
    ¿ø¹ÝȲ¹Ýº¯¼º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AEF Amyloid Enhancing Factor
AH   1) Atrial Hypertrophy
  2) Anti-Hyaluronidase
  3) Amyloid imm...
AL Amyloid immunoglobulin Light chain protein
AP   1) Alkaline Phosphatase
    = ALP
  2) Amyloid Plasm...
FAC Familial Amyloid Cardiomyopathy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NFD Neurofibrillary degeneration
PCD Paraneoplastic cerebellar degeneration
prcd Progressive rod-cone degeneration
PCD Purkinje Cell Degeneration
rds Retinal degeneration slow
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • corneal degeneration
    °¢¸· º¯¼º
  • cystic degeneration
    ³¶»ó º¯¼º, ³¶Á¾ º¯¼º
  • cystoid degeneration
    À¯³¶»ó º¯¼º
  • degeneration of pulp
    Ä¡¼öÀÇ ÅðÈ­
    ³ëÈ­ µîÀÇ ¿µÇâÀ¸·Î Ä¡¼ö°¡ À§ÃàµÇ°í Ä¡¼ö°­ÀÌ Á¼¾ÆÁö´Â °Í.
  • disk degeneration
    ¿øÆÇ º¯¼º
  • fat degeneration
    Áö¹æ º¯¼º
  • fibrinoid degeneration
    ¼¶À¯¼Ò¾ç º¯¼º, ¼¶À¯¾ç º¯¼º
    µ¿ÀǾî=fibrinoid swelling.
  • hyaline degeneration
    À¯¸®Áú º¯¼º
    ¼¼Æ÷ÁúÀÌ ±ÕÁúÀÌ À¯¸® ¸ð¾çÀΠȣ»ê¼ºÀÇ ¸ð¾çÀ» ³ªÅ¸³»´Â ÅðÇ༺ ¼¼Æ÷ º¯È­.
  • joint degeneration
    °üÀý ÅðÇà
  • liquefactive degeneration
    ¾×È­ º¯¼º
  • malignant degeneration
    ¾Ç¼ºÈ­
  • mosaic corneal degeneration
    ¸ðÀÚÀÌÅ© °¢¸· º¯¼º
  • myocardial degeneration
    ½É±Ù º¯¼º
  • myopic degeneration
    ±Ù½Ã¼º º¯¼º
  • neurologic degeneration
    ½Å°æ¼º ÅðÃà
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
amyloid tumour A localised form of amyloidosis in which amyloid occurs as masses or nodules beneath the skin or mucous membranes, e.g., in the larynx.
Synonym: amyloid tumour, focal amyloidosis.
(05 Mar 2000)
beta-amyloid <protein> The protein which forms thick deposits, or plaques, in the brains of people with Alzheimer's disease, a disease where memory skills gradually deteriorate with age.
(13 Nov 1997)
cerebral amyloid angiopathy <pathology> A condition where there is a deposition of amyloid (insoluble protein) in the walls of the arteries which supply the brain. This results in an increased risk of dementia and-or intracerebral haemorrhage. Cerebral amyloidosis or cerebral amyloid angiopathy, is a complication of primary amyloidosis.
Origin: Gr. Pathos = disease
(27 Sep 1997)
serum amyloid In secondary amyloidosis the fibrils deposited in tissues are unrelated to immunoglobulin light chains (in contrast to the situation in primary amyloidosis) and are made of amyloid A protein (AA protein). This is derived from serum amyloid A (SAA) that is the apolipoprotein of a high density lipoprotein and an acute phase protein. Partial proteolysis converts SAA into the pleated sheet configuration of the amyloid fibrils. Amyloid P protein is also found as a minor component of the fibrils (in both primary and secondary amyloidosis) and is derived from serum amyloid P that has similarity to C-reactive protein. The physiological role remains obscure.
(18 Nov 1997)
serum amyloid P component Precursor of amyloid component P, found in basement membrane. Member of the pentraxin family.
See: serum amyloid.
(18 Nov 1997)
islet amyloid peptide <hormone, protein> Peptide of 37 amino acids that selectively inhibits insulin stimulated glucose uptake in muscle. Structurally related to calcitonin gene-related peptide.
(15 Oct 1997)
familial amyloid neuropathy <neurology> A disorder in which various peripheral nerves are infiltrated with amyloid and their functions disturbed, an abnormal prealbumin is also formed and is present in the blood; characteristically, it begins during mid-life and is found largely in persons of Portuguese descent. Other rare clinical types occur.
Inheritance: autosomal dominant.
Synonym: familial amyloidosis, hereditary amyloidosis.
(05 Mar 2000)
adipose degeneration Abnormal formation of microscopically visible droplets of fat in the cytoplasm of cells, as a result of injury.
Synonym: adipose degeneration, steatosis.
(05 Mar 2000)
adiposogenital degeneration A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms.
Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism.
Origin: L. Fr. G. Dys-, bad, + trophe, nourishment
(05 Mar 2000)
age-related macular degeneration A common macular degeneration beginning with drusen of the macula and pigment disruption and sometimes leading to severe loss of central vision.
(05 Mar 2000)
albuminous degeneration An obsolete terms for cloudy swelling.
(05 Mar 2000)
angiolithic degeneration Calcareous degeneration of the walls of the blood vessels.
(05 Mar 2000)
ascending degeneration Retrograde degeneration of an injured nerve fibre; i.e., toward the nerve cell of the fibre, degeneration cephalad to a spinal cord lesion.
(05 Mar 2000)
atheromatous degeneration Focal accumulation of lipid material (atheroma) in the intima and subintimal portion of arteries, eventually resulting in fibrous thickening or calcification.
(05 Mar 2000)
axonal degeneration A type of peripheral nerve fibre response to insult, wherein axon death and subsequent breakdown occurs, with secondary breakdown of the myelin sheath associated; caused by focal injury to peripheral nerve fibres; often referred to as wallerian degeneration.
Synonym: axon degeneration.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á